scholarly journals Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy

2019 ◽  
Vol 157 (6) ◽  
pp. 1506-1517.e1 ◽  
Author(s):  
Anna S. Lok ◽  
Mark S. Sulkowski ◽  
Jens J. Kort ◽  
Ira Willner ◽  
K. Rajender Reddy ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Treatment Failure ◽  
Hepatitis C Virus Infection ◽  
Genotype 1 ◽  
Ns5a Inhibitor

scholarly journals Correction to Discovery of Ledipasvir (GS-5885): A Potent, Once-Daily Oral NS5A Inhibitor for the Treatment of Hepatitis C Virus Infection

2016 ◽  
Vol 59 (16) ◽  
pp. 7696-7696 ◽  
Author(s):  
John O. Link ◽  
James G. Taylor ◽  
Lianhong Xu ◽  
Michael Mitchell ◽  
Hongyan Guo ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Hepatitis C Virus Infection ◽  
Once Daily ◽  
Ns5a Inhibitor

Safety of Glecaprevir/Pibrentasvir in Adults with Chronic Genotype 1-6 Hepatitis C Virus Infection: An Integrated Analysis

2017 ◽  
Vol 152 (5) ◽  
pp. S1089 ◽  
Author(s):  
Jean-Francois DuFour ◽  
Eli Zuckerman ◽  
Neddie Zadeikis ◽  
Christophe Hezode ◽  
Seung Woon Paik ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Integrated Analysis ◽  
Hepatitis C Virus Infection ◽  
Genotype 1

Sofosbuvir Plus Velpatasvir Combination Therapy for Treatment-Experienced Patients With Genotype 1 or 3 Hepatitis C Virus Infection

2015 ◽  
Vol 163 (11) ◽  
pp. 809 ◽  
Author(s):  
Stephen Pianko ◽  
Steven L. Flamm ◽  
Mitchell L. Shiffman ◽  
Sonal Kumar ◽  
Simone I. Strasser ◽  
...  
Keyword(s):  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Virus Infection ◽  
Combination Therapy ◽  
Hepatitis C Virus Infection ◽  
Genotype 1
Sign in / Sign up

Export Citation Format

Share Document